Relypsa, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Relypsa, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					           Relypsa, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH141852D                                                                                                              Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Relypsa, Inc. (Relypsa) is a biopharmaceutical company, based in the US. The
                                                                                                              Relypsa, Inc., Pharmaceuticals & Healthcare, Key
      company discovers and develops non-absorbed polymeric drugs for applications in
                                                                                                              Facts
      cardiovascular and renal diseases. Its drug candidates include RLY5016 and
      RLY106. The company’s product candidate RLY5016 is a non- absorbed potassium                             Web Address                            www.relypsa.com
      binder for the treatment of hyperkalemia. Its drug candidate RLY5016 is used for the
                                                                                                               Revenue (US$ million)                                 NA
      treatment of hyperkalemia, congestive heart failure, chronic kidney disease, end
      stage renal disease, and renin-angiotensin-aldosterone. The company’s investors                          Number of Employees                                   NA
      include OrbiMed, 5AM Ventures, Delphi Ventures, Mediphase Venture Partners,                              GlobalData
      New Leaf Venture Partners, Sprout Group and Amgen.

      Financial Deals Landscape
        Relypsa, Inc., Pharmaceuticals & Healthcare, Deals by Type,                       Relypsa, Inc., Pharmaceuticals & Healthcare, Deals By Year,
        2007 to YTD 2013                                                                  2007 to YTD 2013


                                                                                                                                            2
                                                                                                          2




                                                                                           No. of Deals
                                                                                                                 1                 1                       1
                                                                                                          1


                                                                                                                           0                          0               0
                                                                                                          0
                                                                                                               2007       2008    2009     2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Relypsa, Inc., Pharmaceuticals & Healthcare, Deals By                            Relypsa, Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         6     5                                                                          6           5
          No. of Deals




                                                                                           No. of D…




                         5                                                                                5                            4
                         4                                                                                4                                       3
                                                                                                          3                                                      2
                         3
                                                                                                          2
                         2                                                                                1
                         1              0         0        0         0                                    0
                         0                                                                                       Cardiova         Genito  Hematolo Gastroint
                             North    Asia-     Europe   Middle   South                                           scular          Urinary   gical   estinal
                             Americ   Pacific             East     and                                                            System  Disorder
                               a                          and     Central                                                        And Sex      s
                                                         Africa   Americ                                                         Hormone
                                                                    a                                                                s



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Relypsa, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances                                                                                Reference Code: GDPH141852D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Relypsa, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................................................. 3
       Relypsa, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ............................................................................. 5
       Relypsa, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ......................................................................... 6
       Relypsa, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................................................... 7
       Relypsa, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 .......................................................................... 8
       Relypsa, Inc., Pharmaceuticals & Healthcare, Deal Details ............................................................................................................... 9
          Venture Financing........................................................................................................................................................................... 9
             Relypsa Raises $80 Million In Series C Financing ...................................................................................................................... 9
             Relypsa Secures $70 Million In Series B Financing Round....................................................................................................... 11
             Relypsa Raises $4 Million In Venture Financing ....................................................................................................................... 13
             Relypsa Secures Additional $10 Million In Series A Financing ................................................................................................. 14
             Relypsa Secures $33 Million In Series A Financing .................................................................................................................. 16
       Relypsa, Inc. - Key Competitors ....................................................................................................................................................... 18
       Key Employees ................................................................................................................................................................................ 19
       Locations And Subsidiaries .............................................................................................................................................................. 20
          Head Office ................................................................................................................................................................................... 20
       Appendix .......................................................................................................................................................................................... 21
          Methodology .........................................................................................................................................................
				
DOCUMENT INFO
Description: Relypsa, Inc. (Relypsa) is a biopharmaceutical company, based in the US. The company discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. Its drug candidates include RLY5016 and RLY106. The company’s product candidate RLY5016 is a non- absorbed potassium binder for the treatment of hyperkalemia. Its drug candidate RLY5016 is used for the treatment of hyperkalemia, congestive heart failure, chronic kidney disease, end stage renal disease, and renin-angiotensin-aldosterone. The company’s investors include OrbiMed, 5AM Ventures, Delphi Ventures, Mediphase Venture Partners, New Leaf Venture Partners, Sprout Group and Amgen. Relypsa is headquartered in Santa Clara, California, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.